Andrew M. Creighton

Statistics

Publications

Citations

777

H-Index

Active since

1982

Affiliations

St Bartholomew's Hospital(Current)

The Honourable Society of Lincoln's Inn

University of Manitoba

Andrew M. Creighton is an author at St Bartholomew's Hospital specializing in pharmacology, dna topoisomerase ii inhibition, and topoisomerase ii function.

Publications per year

1982–2002

Publications

A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells

C. Stephen Downes, Duncan J. Clarke, Ann M. Mullinger et al. · Nature · 1994 · 323 citations

Life Sciences, Cell Biology, Molecular Biology +14

A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane)

Brian B. Hasinoff, Theodore I. Kuschak, Jack C. Yalowich et al. · Biochemical Pharmacology · 1995 · 108 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Metal binding by pharmaceuticals. part 2. interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192

Zhong‐Xian Huang, Peter M. May, Kevin M. Quinlan et al. · Inflammation Research · 1982 · 69 citations

Natural Sciences, Biochemistry, Pharmacology +16

Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site

Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozłowska et al. · Molecular Pharmacology · 1997 · 50 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [γ-32P]-ATP

Dario Neri, Heike M. Petrul, Greg Winter et al. · Nature Biotechnology · 1996 · 47 citations

Life Sciences, Biochemistry, Molecular Biology +7

1–5 of 12